|
Current diagnostic guidelines and perpetuation of inequities in ovarian cancer: A National Cancer Database study.
|
May 29, 2024
|
PC3I Authors Anna Jo Smith; Emily Gleason; Anne Marie McCarthy |
Journal of Clinical Oncology
|
|
Transportation assistance in gynecologic oncology: A pilot study.
|
October 26, 2023
|
PC3I Authors Anna Jo Smith; Emily Ko; Justin Bekelman |
JCO Oncology Practice
|
|
Ovarian Cancer Isn’t Just a White Woman’s Disease
|
April 4, 2024
|
PC3I Authors Anna Jo Smith; Emily Ko |
JAMA Oncology
|
|
Insurance-Mediated Disparities in Gynecologic Oncology Care
|
January 6, 2022
|
PC3I Authors Anna Jo Smith; Emily Ko |
Obstetrics & Gynecology
|
|
Predictors of Minimally Invasive Myomectomy in the National Inpatient Sample Database, 2010-2014
|
January 28, 2022
|
PC3I Authors Anna Jo Smith |
JSLS
|
|
Disparities in cancer-specific and overall survival in black women with endometrial cancer: A Medicare-SEER study
|
March 4, 2022
|
PC3I Authors Anna Jo Smith; Emily Ko |
Gynecologic Oncology Reports
|
|
Childbirths at home and in birthing centers rose during COVID-19: Oregon 2020 vs prior years
|
March 20, 2022
|
PC3I Authors Anna Jo Smith |
American Journal of Obstetrics and Gynecology
|
|
Modifiable risk factors associated with long-term survival in women with serous ovarian cancer: a National Cancer Database study
|
April 23, 2022
|
PC3I Authors Anna Jo Smith |
International Journal of Gynecological Cancer
|
|
Association of the Affordable Care Act’s Medicaid Expansion With 1-Year Survival Among Patients With Ovarian Cancer
|
June 8, 2022
|
PC3I Authors Anna Jo Smith |
Obstetrics and Gynecology
|
|
Disparities in biomarker testing in ovarian cancer: a real-world analysis
|
August 25, 2022
|
PC3I Authors Anna Jo Smith; Emily Ko |
American Journal of Obstetrics and Gynecology
|
|
Disparities in Diagnosis and Treatment of Cervical Adenocarcinoma Compared With Squamous Cell Carcinoma: An Analysis of the National Cancer Database, 2004-2017
|
September 14, 2022
|
PC3I Authors Anna Jo Smith |
Journal of Lower Genital Tract Disease
|
|
Prior authorization in gynecologic oncology: An analysis of clinical impact
|
October 16, 2022
|
PC3I Authors Anna Jo Smith; Lakeisha Mulugeta-Gordon; Justin Bekelman; Emily Ko |
Gynecologic Oncology
|
|
Insurance and racial disparities in prior authorization in gynecologic oncology
|
March 21, 2023
|
PC3I Authors Anna Jo Smith; Lakeisha Mulugeta-Gordon; Justin Bekelman; Emily Ko |
Gynecologic Oncology Reports
|
|
Disparities in clinical trial participation in ovarian cancer: A real-world analysis
|
June 10, 2023
|
PC3I Authors Anna Jo Smith; Emily Ko |
Gynecologic Oncology
|
|
Long-term impact of the Affordable Care Act’s dependent coverage mandate on young women with gynecologic cancer
|
June 25, 2023
|
PC3I Authors Anna Jo Smith |
Gynecologic Oncology
|
|
Insurance status and time to radiation care after pathologic diagnosis for cervical cancer patients
|
July 3, 2023
|
PC3I Authors Anna Jo Smith; Emily Ko |
Gynecologic Oncology Reports
|
|
Federal Transportation Regulations Limit Access to Clinical Trials and Oncology Care
|
February 1, 2024
|
PC3I Authors Anna Jo Smith; Emily Ko |
JAMA Oncology
|
|
Variation in telemedicine usage in gynecologic cancer: Are we widening or narrowing disparities?
|
February 6, 2024
|
PC3I Authors Anna Jo Smith; Emily Ko |
Gynecologic Oncology
|
|
Financial toxicity in gynecologic oncology: a multi-practice survey
|
February 12, 2024
|
PC3I Authors Anna Jo Smith; Meredith Doherty; Emily Ko |
International Journal of Gynecological Cancer
|
|
Prior authorization for FDA-approved PARP inhibitors in ovarian cancer
|
February 23, 2024
|
PC3I Authors Anna Jo Smith; Emily Ko |
Gynecologic Oncology Reports
|
